Skip to main content
SpringerLink
Log in

Blood

  • Chapter
  • First Online:
Regenerative Medicine

  • 1591 Accesses

Abstract

The transplantation of stem cells from the bone marrow, peripheral blood or cord blood has become a clinical procedure since the 1980s and is now annually performed in ten thousands of patients in the autologous and allogeneic setting world-wide. Refinement of human leukocyte antigen typing as well as recent advances in immunosuppression, anti-infective prophylaxis and therapy as well in supportive care have much improved the outcome of patients with leukemia and lymphoma, aplastic anemia, as well as hereditary diseases of the hematopoietic system. This is still an experimental therapy and patient subgroups that profit most from hematopoietic stem cell transplantation need to be defined. Consideration and classification of co-morbidity indices as well as cytogenetic risk factors are pivotal for making decisions on transplantation modalities. Modern conditioning regimens allow balancing of allo-effects against malignant cells versus normal tissue even in elderly patients. Recent innovations in cellular therapy combine allogeneic stem cell transplantation with genetically engineered or specifically selected T cells and potentially natural killer (NK) cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009;360:447–58.

    Article  CAS  PubMed  Google Scholar 

  • Amrolia PJ, Almeida A, Davies SC, Roberts IA. Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach. Br.J Haematol. 2003a;120:737–43.

    Article  PubMed  Google Scholar 

  • Amrolia PJ, Almeida A, Halsey C, Roberts IA, Davies SC. Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options. Br.J Haematol. 2003b;120:725–36.

    Article  PubMed  Google Scholar 

  • Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet. 2003;361:553–60.

    Article  PubMed  Google Scholar 

  • Arachchillage DR, Dalley CD, Reilly JT, Wilson G, Collins N, Snowden JA. Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation - single unit dominance is not always the case. Br.J Haematol. 2010; 149(2) 298–9.

    Article  PubMed  Google Scholar 

  • Arachchillage DR, Dalley CD, Reilly JT, Wilson G, Collins N, Snowden JA. Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation - single unit dominance is not always the case. Br.J Haematol. 2010; 149(2)298–9.

    Google Scholar 

  • Bacigalupo A, Passweg J. Diagnosis and treatment of acquired aplastic anemia. Hematol.Oncol Clin North Am. 2009;23:159–70.

    Article  PubMed  Google Scholar 

  • Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA-match on transplant outcome in 1061 cord blood recipients with hematological malignancies. Blood. 2009.

    Google Scholar 

  • Barnes DW, Loutin JF. Protective effects of implants of splenic tissue. Proc.R.Soc.Med. 1953;46:251–2.

    CAS  PubMed  Google Scholar 

  • Beelen, D. W., Gromke, T., Trenschel, R., Hilgendorf, I., Wolff, D., Elmaagacli, A., Freund, M., and Casper, J. Treosulfan compared to total body irradiation-based preparative regimens before allogeneic stem cell transplantation for acute myeloid leukemia : a retrospective long-term study. ASH Annual Meeting Abstracts 112(11), #2149. 16-11–2008.

    Google Scholar 

  • Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplantation 2008;41:109–17.

    Article  CAS  Google Scholar 

  • Bhattacharya D, Czechowicz A, Ooi AG, Rossi DJ, Bryder D, Weissman IL. Niche recycling through division-independent egress of hematopoietic stem cells. J Exp.Med. 2009;206:2837–50.

    Article  CAS  PubMed  Google Scholar 

  • Bortin MM. A compendium of reported human bone marrow transplants. Transplantation. 1970;9:571–87.

    Article  CAS  PubMed  Google Scholar 

  • Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust.J.Exp.Biol.Med.Sci. 1966;44:287–300.

    Article  CAS  PubMed  Google Scholar 

  • Breems DA, Lowenberg B. Acute myeloid leukemia and the position of autologous stem cell transplantation. Seminars in Hematology 2007;44:259–66.

    Article  PubMed  Google Scholar 

  • Casalegno-Garduño R, Schmitt A, Yao J, Wang X, Xu X, Freund M, Schmitt M. Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunol.Immunother. 59:195–202. 2009.

    Google Scholar 

  • Casper, J., Uharek, L., Schäfer-Eckart, K., Wilhelm, S., Knauf, W., Blau, I. W., Steiner, B., Krüger, W., Trentschel, R., Aschan, J., Ringdén, O., Volin, L., Ruutu, T., Wolff, D., Giebel, S., Kröger, N., Holowiecki, J., Zander, A., Hilgendorf, I., Dölken, G., Beelen, D., Thiel, E., Wandt, H., and Freund, M. Toxicity-reduced conditioning with treosulfan and fludarabine prior to allogeneic blood stem cell transplantation for patients with acute myeloid leukemia (AML). Onkologie 28 (suppl. 3), 193. 2005.

    Google Scholar 

  • Colvin GA, Lambert JF, Abedi M, Hsieh CC, Carlson JE, Stewart FM, Quesenberry PJ. Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology. Leukemia. 2004;18:575–83.

    Article  CAS  PubMed  Google Scholar 

  • Czechowicz A, Kraft D, Weissman IL, Bhattacharya D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science. 2007;318:1296–9.

    Article  CAS  PubMed  Google Scholar 

  • Deininger MW. Milestones and monitoring in patients with CML treated with imatinib. Hematology Am.Soc.Hematol.Educ.Program. 2008;419–26.

    Google Scholar 

  • den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, Reinhardus C, Shabanowitz J, Offringa R, Hunt DF, Engelhard VH, Goulmy E. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998;279:1054–7.

    Article  Google Scholar 

  • Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Lowenberg B, Bloomfield CD. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.

    Article  PubMed  Google Scholar 

  • Dreger P. Allotransplantation for chronic lymphocytic leukemia. Hematology Am.Soc.Hematol.Educ.Program. 2009;602–9.

    Google Scholar 

  • Dreger P, Corradini P, Kimby E, Michallet M, Milligan D, Schetelig J, Wiktor-Jedrzejczak W, Niederwieser D, Hallek M, Montserrat E. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia. 2007;21:12–7.

    Article  CAS  PubMed  Google Scholar 

  • EBMT. The EBMT-ESH Handbook – Haematopoietic Stem Cell Transplantation, 5th Edition ed. Genoa, Italy: Forum Service Editore, 2008.

    Google Scholar 

  • Ema H, Takano H, Sudo K, Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J Exp.Med. 2000;192:1281–8.

    Article  CAS  PubMed  Google Scholar 

  • Ford CE, Hammerton JL, Barnes DW, Loutin JF. Cytological identification of radiation-chimaeras. Nature. 1956;177:452–4.

    Article  CAS  PubMed  Google Scholar 

  • Giannopoulos K, Mertens D, Buhler A, Barth TF, Idler I, Moller P, Krober A, Greiner J, Chocholska S, Dmoszynska A, Rolinski J, Dohner H, Stilgenbauer S, Schmitt M. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia. Leukemia. 2009;23:519–27.

    Article  CAS  PubMed  Google Scholar 

  • Ginsburg H, Sachs L. Formation of pure suspension of mast cells in tissue culture by differentiation of lymphoid cells from the mouse thymus. J.Natl.Cancer Inst. 1963;31:1–40.

    CAS  PubMed  Google Scholar 

  • Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.

    Article  CAS  PubMed  Google Scholar 

  • Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Seminars in Hematology 2009;46:64–75.

    Article  PubMed  Google Scholar 

  • Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, Burnett AK, Chopra R, Wiernik PH, Foroni L, Paietta E, Litzow MR, Marks DI, Durrant J, McMillan A, Franklin IM, Luger S, Ciobanu N, Rowe JM. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111:1827–33.

    Article  CAS  PubMed  Google Scholar 

  • Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, Van Rood JJ. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334:281–5.

    Article  CAS  PubMed  Google Scholar 

  • Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, De Witte T, Dini G, Rocha V, Passweg J, Sureda A, Tichelli A, Niederwieser D. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115:4715–26.

    Article  PubMed  Google Scholar 

  • Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J, Ramee JF, Arakelyan N, Thyss A, Molucon-Chabrot C, Delepine R, Milpied N, Colombat P, Deconinck E. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood. 2009;113:995–1001.

    Article  CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint BG, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, MacIntyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–9.

    Article  CAS  PubMed  Google Scholar 

  • Harrison DE, Astle CM. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp.Med. 1982;156:1767–79.

    Article  CAS  PubMed  Google Scholar 

  • Klein J, Sato A. The HLA system. First of two parts. N Engl J Med. 2000a;343:702–9.

    Article  CAS  PubMed  Google Scholar 

  • Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med. 2000b;343:782–6.

    Article  CAS  PubMed  Google Scholar 

  • Kodera Y. The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry. Bone Marrow Transplantation 2008;42 Suppl 1:S6.:S6.

    Article  Google Scholar 

  • Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H, Appelbaum FR, Dohner H, Antin JH, Soiffer RJ, Cutler C. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349–61.

    Article  CAS  PubMed  Google Scholar 

  • Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk KM, Verdonck LF, Beck J, Dohner H, Gratwohl A, Pabst T, Verhoef G. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med. 2009;361:1235–48.

    Article  PubMed  Google Scholar 

  • Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma. J Clin Oncol. 1995;13:588–95.

    CAS  PubMed  Google Scholar 

  • Moretta A, Pende D, Locatelli F, Moretta L. Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. Clin Exp.Immunol. 2009;157:325–31.

    Article  CAS  PubMed  Google Scholar 

  • Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 1996;5:207–16.

    Article  CAS  PubMed  Google Scholar 

  • Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat.Med. 1999;5:839–42.

    Article  CAS  PubMed  Google Scholar 

  • Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, Mahlaoui N, Debre M, Casanova JL, Dal Cortivo L, Madec Y, Hacein-Bey-Abina S, de Saint BG, de Villartay JP, Blanche S, Cavazzana-Calvo M, Fischer A. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113:4114–24.

    Article  CAS  PubMed  Google Scholar 

  • Nowell PC, Cole LJ, Habermeyer JG, Roan PL. Growth and continued function of rat marrow cells in x-radiated mice. Cancer Research 1956;16:258–61.

    CAS  PubMed  Google Scholar 

  • Papayannopoulou T, Scadden DT. Stem-cell ecology and stem cells in motion. Blood. 2008;111:3923–30.

    Article  CAS  PubMed  Google Scholar 

  • Piccin A, McCann S, Socie G, Oneto R, Bacigalupo A, Locasciulli A, Marsh J, Schrezenmeier H, Tichelli A, Hand E, Lawler M, Passweg J. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT. Bone Marrow Transplantation 2009.

    Google Scholar 

  • Rammensee HG, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu.Rev.Immunol. 1993;11:213-44.:213–44.

    Article  CAS  PubMed  Google Scholar 

  • Ringhoffer M, Harsdorf S, Schmitt M, Wiesneth M, Zenz T, Stilgenbauer S, Greiner J, Dohner K, Marx M, Dohner H, Bunjes D. Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse. Br.J Haematol. 2007;136:127–30.

    Article  PubMed  Google Scholar 

  • Saussele S, Lauseker M, Gratwohl A, Beelen DW, Bunjes D, Schwerdtfeger R, Kolb HJ, Ho AD, Falge C, Holler E, Schlimok G, Zander AR, Arnold R, Kanz L, Dengler R, Haferlach C, Schlegelberger B, Pfirrmann M, Muller MC, Schnittger S, Leitner A, Pletsch N, Hochhaus A, Hasford J, Hehlmann R. Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; evaluation of its impact within a subgroup of the randomized German CML Study IV. Blood. 2009.

    Google Scholar 

  • Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L, Habdank M, Spath D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Dohner H. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–18.

    Article  CAS  PubMed  Google Scholar 

  • Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, Volin L, Gurman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938–45.

    Article  CAS  PubMed  Google Scholar 

  • Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weisinger E, Bunjes D, von Harsdorf S, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb H-J. Longterm survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 2006;108:1092–9.

    Article  CAS  PubMed  Google Scholar 

  • Schmitt, A., Tonn, T., Busch, D., Grigoleit, G., Einsele, H., Odenthal, M., Germeroth, L., Ringhoffer, M., Ringhoffer, S., Wiesneth, M., Detlef, M., Mertens, Th., Rojewski, M., Marx, M., Harsdorf, S., Döhner, H., Seifried, E., Bunjes, D., and Schmitt, M. Adoptive Transfer and Consequential Selective Reconstitution of Streptamer-Selected Cytomegalovirus-Specific CD8+ T Cells Leads to Enduring Virus Clearance in Patients after Allogeneic Stem Cell Transplantation. Blood (ASH Annual Meeting Abstracts) 112, 1181. 2008.

    Google Scholar 

  • Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110:1397–400.

    Article  CAS  PubMed  Google Scholar 

  • Sodani P, Isgro A, Gaziev J, Polchi P, Paciaroni K, Marziali M, Simone MD, Roveda A, Montuoro A, Alfieri C, De Angelis G, Gallucci C, Erer B, Isacchi G, Zinno F, Adorno G, Lanti A, Faulkner L, Testi M, Andreani M, Lucarelli G. Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood. 2009.

    Google Scholar 

  • Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84:941–9.

    CAS  PubMed  Google Scholar 

  • Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation. N Engl J Med. 1975;292:832–43, 895–902.

    Article  CAS  PubMed  Google Scholar 

  • Thomas ED, Lochte Jr. HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957;257:491–6.

    Article  CAS  PubMed  Google Scholar 

  • Trowsdale J, Campbell RD. Physical map of the human HLA region. Immunol Today 1988;9:134–7.

    Article  Google Scholar 

  • Vos O, Davids JA, Weyzen WW, van Bekkum DW. Evidence for the cellular hypothesis in radiation protection by bone marrow cells. Acta Physiol Pharmacol.Neerl. 1956;4:482–6.

    CAS  PubMed  Google Scholar 

  • Wang, X., Schmitt, A., Germeroth, L., Freund, M., and Schmitt, M. Generation of leukaemia antigen-specific donor lymphocyte infusions powered by streptamer-based selection. Bone Marrow Transplantation 43, S73. 2009.

    Google Scholar 

  • Yanada M, Matsuo K, Suzuki T, Naoe T. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis. Cancer. 2006;106:2657–63

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, University of Rostock, Ernst-Heydemann-Strasse 6, Rostock, 18057, Germany

    Michael Schmitt & Mathias Freund

Authors
  1. Michael Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathias Freund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Schmitt .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Herzchirurgie, Universitätsklinikum Rostock, Schillingallee 35, Rostock, 18057, Germany

    Gustav Steinhoff

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Netherlands

About this chapter

Cite this chapter

Schmitt, M., Freund, M. (2011). Blood. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9075-1_23

Download citation

Publish with us

Policies and ethics

Search

Navigation